These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 13225986)

  • 1. A circulating anticoagulant selectively active against human antihemophilic factor (autoimmune hemophilia).
    SPAET TH; KINSELL BG
    Stanford Med Bull; 1954 Nov; 12(4):246-56. PubMed ID: 13225986
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the nature of the circulating anticoagulant directed against antihemophilic factor: with notes on an assay for anthemophilic factor.
    BRECKENRIDGE RT; RATNOFF CD
    Blood; 1962 Aug; 20():137-49. PubMed ID: 13872719
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemophilias with major deficiency in antihemophilic factor. Von Willebrand's disease. Circulating anti-AHG anti-AHG anticoagulants].
    Guimbretére J
    Anesth Analg (Paris); 1975; 32(4):577-64. PubMed ID: 1084106
    [No Abstract]   [Full Text] [Related]  

  • 4. In-vivo study on the relation between Bridge anticoagulant and antihaemophilic globulin.
    NOUR-ELDIN F; WILKINSON JF
    Br J Haematol; 1958 Jul; 4(3):292-301. PubMed ID: 13572740
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemophilia A with presence in the serum of a specific inhibitor of antihemophilic B globulin].
    STEFANOVIC S; ROLOVIC Z; BOZINOVIC L
    Hemostase; 1961 Jun; 1():135-41. PubMed ID: 13916528
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma antihemophilic factor biological and clinical aspects.
    BRINKHOUS KM
    Sang; 1954; 25(7):738-41. PubMed ID: 13225559
    [No Abstract]   [Full Text] [Related]  

  • 7. [Appearance of an antithrombin following thrombin injections in a hemophilic having presented a circulating anticoagulant].
    SOULIER JP
    Rev Hematol; 1953; 8(1):39-43. PubMed ID: 13101088
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of the preservation of the A and B antihemophilic factors in lyophylized plasma].
    DUCOS J; BIERME R
    Rev Fr Etud Clin Biol; 1959 Dec; 4():1057-9. PubMed ID: 13818417
    [No Abstract]   [Full Text] [Related]  

  • 9. [Does lyophilization cause the appearance of a non-specific thromboplastic activity in the blood? Study of the antihemophilic factors A and B].
    DUCOS J; BIERME R
    C R Seances Soc Biol Fil; 1960; 154():808-12. PubMed ID: 13724735
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative determination of the antihemophilic globulin in both sexes].
    FISCHER J; LANDBECK G; LENZ W
    Klin Wochenschr; 1958 Jan; 36(1):20-2. PubMed ID: 13540108
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum accelerator factors and antihemophilic factor (AHF) in early phases of clotting.
    GRAHAM JB; LANGDELL RD; MORRISON FC; BRINKHOUS KM
    Proc Soc Exp Biol Med; 1954 Oct; 87(1):45-8. PubMed ID: 13224672
    [No Abstract]   [Full Text] [Related]  

  • 12. Researches on a circulating anticoagulant in a hemophiliac.
    VAN CREVELD S; HOORWEG PG; PAULSSEN MM
    Blood; 1953 Feb; 8(2):125-30. PubMed ID: 13018346
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunologic studies of antihemophilic factor (AHF, factor VIII): cross-reacting material in a genetic variant of hemophilia A.
    Hoyer LW; Breckenridge RT
    Blood; 1968 Dec; 32(6):962-71. PubMed ID: 5303720
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on human factor VIII (antihemophilic factor). I. Purification and properties of factor VIII (author's transl)].
    Niiya K
    Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):534-42. PubMed ID: 308760
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of blood coagulation in hemophilia].
    FRANCESCON M; BUTTO M; MASETTO I
    Riforma Med; 1953 Aug; 67(34):942-5. PubMed ID: 13101410
    [No Abstract]   [Full Text] [Related]  

  • 16. Antihemophilic factor (AHF): plasma levels after administration of AHF preparations to hemophilic dogs.
    WAGNER RH; LANGDELL RD; RICHARDSON BA; FARRELL RA; BRINKHOUS KM
    Proc Soc Exp Biol Med; 1957 Oct; 96(1):152-5. PubMed ID: 13485042
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prothrombin level in hemophilic blood after the addition in vitro of Cohn's fraction Ia (antihemophilic globulin)].
    TROPEANO L
    Boll Soc Ital Biol Sper; 1952 Dec; 28(12):1892-4. PubMed ID: 13059109
    [No Abstract]   [Full Text] [Related]  

  • 18. [The consumption of antihemophilic globulin and the development of thromboplastin accelerator power in the adsorbed plasma-recalcified serum mixture. The problem of the responsible serum substrate].
    MAYER G; MAYER S; WAITZ R
    Rev Fr Etud Clin Biol; 1961 Nov; 6():924-8. PubMed ID: 14471688
    [No Abstract]   [Full Text] [Related]  

  • 19. Heterogeneity of human circulating anticoagulants against antihemophilic factor (factor VIII).
    Poon MC; Wine AC; Ratnoff OD; Bernier GM
    Blood; 1975 Sep; 46(3):409-16. PubMed ID: 50101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunological properties of factor VIII. I. Studies on the inhibitory activity of specific antisera to human antihemophilic globulin.
    Uszyński L
    Thromb Diath Haemorrh; 1966 Dec; 16(3):558-73. PubMed ID: 5301276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.